Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
53,624,393
-
Share change
-
+2,415,813
-
Total reported value
-
$3,206,365,565
-
Put/Call ratio
-
574%
-
Price per share
-
$59.85
-
Number of holders
-
317
-
Value change
-
+$162,150,149
-
Number of buys
-
154
-
Number of sells
-
156
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q2 2018
As of 30 Jun 2018,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
317 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,624,393 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, Champlain Investment Partners, LLC, ACADIAN ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, and FMR LLC.
This page lists
317
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.